Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab.
Kroemer A, Belyayev L, Khan K, Loh K, Kang J, Duttargi A, Dhani H, Sadat M, Aguirre O, Gusev Y, Bhuvaneshwar K, Kallakury B, Cosentino C, Houlihan B, Diaz J, Moturi S, Yazigi N, Kaufman S, Subramanian S, Hawksworth J, Girlanda R, Robson SC, Matsumoto CS, Zasloff M, Fishbein TM.
Kroemer A, et al.
Am J Transplant. 2021 Mar;21(3):1238-1254. doi: 10.1111/ajt.16283. Epub 2020 Sep 25.
Am J Transplant. 2021.
PMID: 32882110
Free PMC article.